JPMorgan analyst Anne Samuel reiterated an Overweight rating and $45.00 price target on Evolent Health (NYSE: EVH).The analyst comments "Following ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Momentum Movers Trader Talk

Piper Sandler Downgrades Humana (HUM) to NeutralOctober 3, 2024 9:35 AM Raymond James Reiterates Market Perform Rating on Humana (HUM)October 3, 2024 6:17 AM Wells Fargo Reiterates Overweight Rating on Humana (HUM)October 3, 2024 5:55 AM Bernstein SocGen Group Reiterates Market Perform Rating on Humana (HUM)October 3, 2024 5:52 AM Barclays Takeaways from Humana (HUM) Mgmt CallOctober 2, 2024 1:23 PM Truist Securities Reiterates Buy Rating on Evolent Health (EVH)September 30, 2024 6:07 AM